Rui Rolo

[Andre' Carvalho @meldincarvalho]

Join us for the 13th Oporto ILD Meeting in April

Programme: https://t.co/VNaseugcIU

Registration (FREE for the International Symposium @ 5-6 April AND available ONLINE): https://t.co/qTPSEJGLcu

[Rui Rolo @ruirolo3]

@IsabelLMMoreira Só conseguiu acertar na primeira frase.

[Rui Rolo @ruirolo3]

@joanarcordeiro Tudo errado no que escreveu do princípio ao fim. E espero é que a IL seja mais adulta nesta matéria.

[Rui Rolo @ruirolo3]

@jonherochung @leticiakawano Great lecture on imaging in sarcoidosis Jonathan!

[Rui Rolo @ruirolo3]

ERS Congress - novel treatments for #pulmonaryfibrosis

[Rui Rolo @ruirolo3]

@leticiakawano Present! 👍

[Rui Rolo @ruirolo3]

@adrijobecq A completa falta de noção começa logo em querer comparar salários de um grupo profissional que tem mais qualificações e responsabilidade profissional que 95% dos portugueses.

[Rui Rolo @ruirolo3]

@leticiakawano @dadourado @PerVandvik Também no Algarve 😎 praia de altura

[Rui Rolo @ruirolo3]

@leticiakawano @dadourado @fran_becher Ontem foi dia de festejo em Lisboa 😁

[Rui Rolo @ruirolo3]

@leticiakawano @RaphaelBorie @OrphaLung @Katerin16265046 @DrPeter_George Lá estaremos 😁

[Rui Rolo @ruirolo3]

@leticiakawano @jonherochung @atscommunity @accpchest Estou cá 😁

[Rui Rolo @ruirolo3]

@leticiakawano Great session with fantastic speakers! So nice to meet you in person. Hope to see you soon with us in forthcoming SPP - ILD working group meetings.

[Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn) @leticiakawano]

1/ Outstanding discussion at #SPP2022 on the diagnosis of #pulmonaryfibrosis *progression* for purposes of managing an individual patient:
#PPF #progressivePF
Highlights:
❌1 year time frame to define progression? Doesn't make sense

+

[Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn) @leticiakawano]

1/ Thought-provoking study in hypersensitivity pneumonitis:

Are we doing good to fHP patients by treating them with steroids?
And what about immunosuppression? There are no RCTs available to guide us here...

In this single-center cohort +
https://t.co/LekCBZqVpi